Abstract
Several studies linked depression as an independent risk factor for the onset of cardiovascular disease. One reason for this correlation is the exacerbation of platelet activity described in patients diagnosed with Major Depressive Disorder (MDD). Among the therapeutic possibilities for depressed patients, selective serotonin reuptake inhibitors (SSRIs) demonstrate anti-aggregating abilit…